Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 191

1.

Contributions of a regional approach to document hematologic disease in Mexico: a 10-year experience in an open population.

Jaime-Pérez JC, Treviño-Reyna G, Aguilar-Calderón P, Cantú-Rodríguez OG, Marfil-Rivera LJ, Gómez-Almaguer D.

Hematology. 2018 Jul 16:1-7. doi: 10.1080/10245332.2018.1498166. [Epub ahead of print]

PMID:
30010502
2.

Platelet Survival in Hematology Patients Assessed by the Corrected Count Increment and Other Formulas.

Jaime-Pérez JC, Vázquez-Hernández KE, Jiménez-Castillo RA, Fernández LT, Salazar-Riojas R, Gómez-Almaguer D.

Am J Clin Pathol. 2018 Jul 5. doi: 10.1093/ajcp/aqy052. [Epub ahead of print]

PMID:
29982409
3.

Iron deficiency anemia referral to the hematologist. Real-world data from Mexico: the need for targeted teaching in primary care.

López-García YK, Colunga-Pedraza PR, Tarín-Arzaga L, López Garza MI, Jaime-Pérez JC, Gómez-Almaguer D.

Hematology. 2018 Apr 11:1-6. doi: 10.1080/10245332.2018.1461290. [Epub ahead of print]

PMID:
29637844
4.

Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.

Jaime-Pérez JC, Padilla-Medina JR, Fernández LT, Herrera-Garza JL, Gutiérrez-Aguirre CH, Tarín-Arzaga L, Gómez-Almaguer D.

Clin Lymphoma Myeloma Leuk. 2018 Apr;18(4):286-292. doi: 10.1016/j.clml.2018.02.002. Epub 2018 Feb 8.

PMID:
29478946
5.

Impact of the affordability of novel agents in patients with multiple myeloma: Real-world data of current clinical practice in Mexico.

Tarín-Arzaga L, Arredondo-Campos D, Martínez-Pacheco V, Martínez-González O, Ramírez-López A, Gómez-De León A, Gutiérrez-Aguirre CH, Cantú-Rodríguez O, Jaime-Pérez JC, Gómez-Almaguer D.

Cancer. 2018 May 1;124(9):1946-1953. doi: 10.1002/cncr.31305. Epub 2018 Feb 20.

PMID:
29461639
6.

Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas.

Kardduss-Urueta A, Gale RP, Gutierrez-Aguirre CH, Herrera-Rojas MA, Murrieta-Álvarez I, Perez-Fontalvo R, Ruiz-Delgado GJ, Ruiz-Rojas G, Jaimovich G, Feldman L, Labastida-Mercado N, Endara A, Castro M, Galindo-Becerra S, Cardona-Molina MA, Gomez-Almaguer D, Ruiz-Argüelles GJ.

Bone Marrow Transplant. 2018 Apr;53(4):457-460. doi: 10.1038/s41409-017-0047-7. Epub 2018 Jan 12.

PMID:
29330390
7.

Eltrombopag, low-dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia.

Gómez-Almaguer D, Colunga-Pedraza PR, Gómez-De León A, Gutiérrez-Aguirre CH, Cantú-Rodríguez OG, Jaime-Pérez JC.

Br J Haematol. 2017 Dec 21. doi: 10.1111/bjh.15070. [Epub ahead of print] No abstract available.

PMID:
29270980
8.

Danazol as First-Line Therapy for Myelodysplastic Syndrome.

Colunga-Pedraza PR, Colunga-Pedraza JE, Garza-Ledezma MA, Jaime-Pérez JC, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Rendón-Ramírez EJ, López-García YK, Lozano-Morales RE, Gómez-De León A, Sotomayor-Duque G, Gómez-Almaguer D.

Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):e109-e113. doi: 10.1016/j.clml.2017.11.007. Epub 2017 Nov 29.

PMID:
29268959
9.

High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center.

Jaime-Pérez JC, Gamboa-Alonso CM, Padilla-Medina JR, Jiménez-Castillo RA, Olguín-Ramírez LA, Gutiérrez-Aguirre CH, Cantú-Rodríguez OG, Gómez-Almaguer D.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):325-330. doi: 10.1016/j.bjhh.2017.08.001. Epub 2017 Sep 14.

10.

Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia.

Jaime-Pérez JC, Borrego-López MF, Jiménez-Castillo RA, Méndez-Ramírez N, Salazar-Riojas R, Fernández LT, Gómez-Almaguer D.

Int J Lab Hematol. 2018 Apr;40(2):169-174. doi: 10.1111/ijlh.12760. Epub 2017 Nov 8.

PMID:
29115725
11.

The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study.

Gutiérrez-Aguirre CH, Flores-Jiménez JA, Alatorre-Ricardo J, Cantú-Rodríguez OG, Rosas-Taraco A, Salazar-Riojas R, Jaime-Pérez JC, Sánchez-Cárdenas M, López-Silva L, Martínez-Castilla AM, Salinas-Carmona MC, Gómez-Almaguer D.

Ann Hematol. 2017 Dec;96(12):2015-2024. doi: 10.1007/s00277-017-3142-3. Epub 2017 Oct 13.

PMID:
29027574
12.

Do immunoglobulin G and immunoglobulin E anti-l-asparaginase antibodies have distinct implications in children with acute lymphoblastic leukemia? A cross-sectional study.

Galindo-Rodríguez G, Jaime-Pérez JC, Salinas-Carmona MC, González-Díaz SN, Castro-Corona Á, Cavazos-González R, Treviño-Villarreal H, Heredia-Salazar AC, Gómez-Almaguer D.

Rev Bras Hematol Hemoter. 2017 Jul - Sep;39(3):202-209. doi: 10.1016/j.bjhh.2016.11.006. Epub 2017 Jan 24.

13.

Economic Challenges in Hematopoietic Cell Transplantation: How Will New and Established Programs Face the Growing Costs?

Weisdorf D, Ruiz-Arguelles GJ, Srivastava A, Gómez-Almaguer D, Szer J.

Biol Blood Marrow Transplant. 2017 Nov;23(11):1815-1816. doi: 10.1016/j.bbmt.2017.07.026. Epub 2017 Aug 7. No abstract available.

PMID:
28797786
14.

The effect of intra-articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis.

Garay-Mendoza D, Villarreal-Martínez L, Garza-Bedolla A, Pérez-Garza DM, Acosta-Olivo C, Vilchez-Cavazos F, Diaz-Hutchinson C, Gómez-Almaguer D, Jaime-Pérez JC, Mancías-Guerra C.

Int J Rheum Dis. 2018 Jan;21(1):140-147. doi: 10.1111/1756-185X.13139. Epub 2017 Jul 27.

PMID:
28752679
15.

Insights into the management of chronic myeloid leukemia in resource-poor settings: a Mexican perspective.

Gomez-de-León A, Gómez-Almaguer D, Ruiz-Delgado GJ, Ruiz-Arguelles GJ.

Expert Rev Hematol. 2017 Sep;10(9):809-819. doi: 10.1080/17474086.2017.1360180. Epub 2017 Aug 3. Review.

PMID:
28742419
16.

Age Acts as an Adverse Independent Variable for Survival in Acute Lymphoblastic Leukemia: Data From a Cohort in Northeast Mexico.

Jaime-Pérez JC, Fernández LT, Jiménez-Castillo RA, Gómez-De León A, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Gómez-Almaguer D.

Clin Lymphoma Myeloma Leuk. 2017 Sep;17(9):590-594. doi: 10.1016/j.clml.2017.06.016. Epub 2017 Jun 17.

PMID:
28689002
17.

Hospitalization rate and costs in acute lymphoblastic leukemia of childhood in a low-income group: Financial impact in Northeast Mexico.

Jaime-Pérez JC, Fernández LT, Jiménez-Castillo RA, Colunga-Pedraza JE, Padilla-Medina JR, Mancías-Guerra C, Gómez-Almaguer D.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26673. Epub 2017 Jun 9.

PMID:
28598592
18.

Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor.

Jaime-Pérez JC, Pinzón-Uresti MA, Jiménez-Castillo RA, Colunga-Pedraza JE, González-Llano Ó, Gómez-Almaguer D.

Hematology. 2018 Jan;23(1):1-9. doi: 10.1080/10245332.2017.1333294. Epub 2017 Jun 3.

PMID:
28580844
19.

Frecuencia de sobrecarga de hierro en pacientes con enfermedades hematológicas.

Flores-Jiménez JA, Saldaña-Vázquez R, Villarreal-Martínez L, Gutiérrez-Aguirre CH, Jaime-Pérez JC, Cantú-Rodríguez OG, González-Llano O, Gómez-Almaguer D.

Salud Publica Mex. 2017 Mar-Apr;59(2):120-122. doi: 10.21149/8179. Spanish. No abstract available.

PMID:
28562706
Free Article
20.

Results of Treating Childhood Acute Lymphoblastic Leukemia in a Low-middle Income Country: 10 Year Experience in Northeast Mexico.

Jaime-Pérez JC, López-Razo ON, García-Arellano G, Pinzón-Uresti MA, Jiménez-Castillo RA, González-Llano O, Gómez-Almaguer D.

Arch Med Res. 2016 Nov;47(8):668-676. doi: 10.1016/j.arcmed.2017.01.004.

PMID:
28476194

Supplemental Content

Loading ...
Support Center